The potential role of follicular helper T cells in idiopathic multicentric Castleman disease with and without TAFRO syndrome

被引:8
|
作者
Kurose, Nozomu [1 ]
Guo, Xin [1 ]
Shioya, Akihiro [1 ]
Mizutani, Ken-ichi [1 ]
Kumagai, Motona [1 ]
Fujimoto, Shino [2 ]
Kawabata, Hiroshi [2 ]
Masaki, Yasufumi [2 ]
Takai, Kazue [3 ]
Aoki, Sadao [4 ]
Nakamura, Shigeo [5 ]
Yamada, Sohsuke [1 ]
机构
[1] Dept Pathol & Lab Med, Uchinada, Ishikawa, Japan
[2] Kanazawa Med Univ, Dept Hematol & Immunol, Uchinada, Ishikawa, Japan
[3] Niigata City Gen Hosp, Div Hematol, Niigata, Japan
[4] Niigata Univ Pharm & Appl Life Sci, Fac Pharmaceut Sci, Dept Pathophysiol, Niigata, Japan
[5] Nagoya Univ, Dept Pathol & Biol Response, Grad Sch Med, Nagoya, Aichi, Japan
关键词
TAFRO syndrome; Follicular helper T cell; IgG4-related disease; CXCR5; CD40L; DIFFERENTIATION; EXPRESSION; PATHOGENESIS;
D O I
10.1016/j.prp.2019.152563
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Idiopathic multicentric Castleman disease (iMCD) is a systemic inflammatory disease of unknown etiology caused by hypercytokinemia. Recently, TAFRO (thrombocytopenia, gnasarca, fever, renal failure or reticulin fibrosis, and organomegaly) syndrome has been reported, which shows similar histopathological findings to iMCD and factors associated with a poor prognosis. IMCD shows no plasma cell infiltration in the germinal center (GC), but CD38-positive (CD38(+))-plasma cells are observed in the interfollicular area. Our previous report revealed that atrophic change of GC, glomeruloid vascular proliferation, and abnormal proliferation of follicular dendritic cells are more prominent in iMCD with TAFRO (TAFRO +) in comparison to iMCD without TAFRO (TAFRO ). In addition, the numbers of CD38(+) and immunoglobulin G4-positive (IgG4(+)) plasma cells were decreased in the interfollicular area. The roles of T follicular helper cells (Tfh) are well-known to assist B-cell proliferation, maturation, and differentiation . It maintains the formation of GC and is also related in the class switching of IgG isotypes, including IgG4. Thus, we immunohistochemically examined the number of Tfh in GCs in both TAFRO(-) and TAFRO(+) iMCD. The number of Tfh was significantly decreased in TAFRO(-) iMCD (n = 9) and was further decreased in TAFRO(+) iMCD (n = 18) in comparison to non-specific lymphadenopathy (n = 6) and IgG4-related disease (n = 4). These results suggest that decreased Tfh may be one etiology of iMCD.
引用
收藏
页数:6
相关论文
共 50 条
  • [1] Is TAFRO syndrome a subtype of idiopathic multicentric Castleman disease?
    Fujimoto, Shino
    Sakai, Tomoyuki
    Kawabata, Hiroshi
    Kurose, Nozomu
    Yamada, Sohsuke
    Takai, Kazue
    Aoki, Sadao
    Kuroda, Junya
    Ide, Makoto
    Setoguchi, Keigo
    Tsukamoto, Norifumi
    Iwao-Kawanami, Haruka
    Kawanami, Takafumi
    Mizuta, Shuichi
    Fukushima, Toshihiro
    Masaki, Yasufumi
    AMERICAN JOURNAL OF HEMATOLOGY, 2019, 94 (09) : 975 - 983
  • [2] An extranodal histopathological analysis of idiopathic multicentric Castleman disease with and without TAFRO syndrome
    Kurose, Nozomu
    Mizutani, Ken-ichi
    Kumagai, Motona
    Shioya, Akihiro
    Guo, Xin
    Nakada, Satoko
    Fujimoto, Shino
    Kawabata, Hiroshi
    Masaki, Yasufumi
    Takai, Kazue
    Aoki, Sadao
    Kojima, Masaru
    Nakamura, Shigeo
    Kida, Masatoshi
    Yamada, Sohsuke
    PATHOLOGY RESEARCH AND PRACTICE, 2019, 215 (03) : 410 - 413
  • [3] IDIOPATHIC MULTICENTRIC CASTLEMAN DISEASE WITH TAFRO SYNDROME AND SJOGREN SYNDROME
    Durant, Catherine
    Balasubramanian, Shailesh
    CHEST, 2022, 162 (04) : 1020A - 1021A
  • [4] TAFRO Syndrome Without Pathology Supporting Castleman Disease: To Be Treated as Idiopathic Multicentric Castleman Disease-TAFRO or a Distinct Disease Entity?
    Li, Si-Yuan
    Gao, Yu-Han
    Dang, Yue
    Zhang, Lu
    Li, Jian
    TURKISH JOURNAL OF HEMATOLOGY, 2025, 42 (01) : 1 - 8
  • [5] A Rare Variant of Idiopathic Multicentric Castleman Disease: TAFRO Syndrome
    Uk, Ece
    Akin, Alper
    Gulseren, Ubeyde Ayse
    Erdem, Simge
    Medetalibeyoglu, Alpay
    TURKISH JOURNAL OF HEMATOLOGY, 2022, 39 (03) : 215 - 217
  • [6] TAFRO syndrome: New subtype of idiopathic multicentric Castleman disease
    Srkalovic, Gordan
    Marijanovic, Inga
    Srkalovic, Maya B.
    Fajgenbaum, David C.
    BOSNIAN JOURNAL OF BASIC MEDICAL SCIENCES, 2017, 17 (02) : 81 - 84
  • [7] Idiopathic multicentric Castleman disease of TAFRO subtype
    Godfrey, Katherine
    Harris, Emma
    Moss, Hilary
    Martin-Cabrera, Pedro
    BRITISH JOURNAL OF HAEMATOLOGY, 2022, 196 (03) : 461 - 461
  • [8] The clinicopathological comparison among nodal cases of idiopathic multicentric Castleman disease with and without TAFRO syndrome
    Kurose, Nozomu
    Futatsuya, Chizuru
    Mizutani, Ken-ichi
    Kumagai, Motona
    Shioya, Akihiro
    Guo, Xin
    Aikawa, Akane
    Nakada, Satoko
    Fujimoto, Shino
    Kawabata, Hiroshi
    Masaki, Yasufumi
    Takai, Kazue
    Aoki, Sadao
    Kojima, Masaru
    Nakamura, Shigeo
    Yamada, Sohsuke
    HUMAN PATHOLOGY, 2018, 77 : 130 - 138
  • [9] Idiopathic multicentric Castleman's disease with TAFRO syndrome: a case report
    Khan, A., I
    Khan, A.
    Hanan, A.
    Geetha, S.
    Sticco, K.
    Sheikh-Fayyaz, S.
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2023, 160 : S78 - S78
  • [10] Idiopathic multicentric Castleman's disease with TAFRO syndrome: a case report
    Khan, A. I.
    Khan, A.
    Hanan, A.
    Geetha, S.
    Sticco, K.
    Sheikh-Fayyaz, S.
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2023, 160 : S78 - S78